157 related articles for article (PubMed ID: 37323180)
1. Assessing how lung cancer screening guidelines contribute to racial disparities in screening access.
Ivic-Pavlicic T; Joshi S; Zegarelli A; Taioli E
Transl Lung Cancer Res; 2023 May; 12(5):1122-1132. PubMed ID: 37323180
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Eligibility for Lung Cancer Screening by Race After 2021 Changes to US Preventive Services Task Force Screening Guidelines.
Pinheiro LC; Groner L; Soroka O; Prosper AE; Jack K; Tamimi RM; Safford M; Phillips E
JAMA Netw Open; 2022 Sep; 5(9):e2229741. PubMed ID: 36053535
[TBL] [Abstract][Full Text] [Related]
3. Validation of a Deep Learning-Based Model to Predict Lung Cancer Risk Using Chest Radiographs and Electronic Medical Record Data.
Raghu VK; Walia AS; Zinzuwadia AN; Goiffon RJ; Shepard JO; Aerts HJWL; Lennes IT; Lu MT
JAMA Netw Open; 2022 Dec; 5(12):e2248793. PubMed ID: 36576736
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations.
Reese TJ; Schlechter CR; Potter LN; Kawamoto K; Del Fiol G; Lam CY; Wetter DW
JAMA Netw Open; 2021 Jan; 4(1):e2033769. PubMed ID: 33433600
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
[TBL] [Abstract][Full Text] [Related]
6. Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
Bassett MT; Chen JT; Krieger N
PLoS Med; 2020 Oct; 17(10):e1003402. PubMed ID: 33079941
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
[TBL] [Abstract][Full Text] [Related]
9. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening.
Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU
J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717
[TBL] [Abstract][Full Text] [Related]
10. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers.
Aldrich MC; Mercaldo SF; Sandler KL; Blot WJ; Grogan EL; Blume JD
JAMA Oncol; 2019 Sep; 5(9):1318-1324. PubMed ID: 31246249
[TBL] [Abstract][Full Text] [Related]
12. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436
[TBL] [Abstract][Full Text] [Related]
13. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
[TBL] [Abstract][Full Text] [Related]
14. Racial and Ethnic Disparities in Lung Cancer Screening Eligibility.
Narayan AK; Chowdhry DN; Fintelmann FJ; Little BP; Shepard JO; Flores EJ
Radiology; 2021 Dec; 301(3):712-720. PubMed ID: 34546133
[TBL] [Abstract][Full Text] [Related]
15. Impact of U.S. Preventive Services Task Force lung cancer screening update on drivers of disparities in screening eligibility.
Maki KG; Talluri R; Toumazis I; Shete S; Volk RJ
Cancer Med; 2023 Feb; 12(4):4647-4654. PubMed ID: 35871312
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
[TBL] [Abstract][Full Text] [Related]
17. Eligibility Criteria for Lower Extremity Joint Replacement May Worsen Racial and Socioeconomic Disparities.
Wang AY; Wong MS; Humbyrd CJ
Clin Orthop Relat Res; 2018 Dec; 476(12):2301-2308. PubMed ID: 30303879
[TBL] [Abstract][Full Text] [Related]
18. Disparities of National Lung Cancer Screening Guidelines in the US Population.
Han SS; Chow E; Ten Haaf K; Toumazis I; Cao P; Bastani M; Tammemagi M; Jeon J; Feuer EJ; Meza R; Plevritis SK
J Natl Cancer Inst; 2020 Nov; 112(11):1136-1142. PubMed ID: 32040195
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]